Literature DB >> 31952782

Regulatory Factor X 7 and its Potential Link to Lymphoid Cancers.

Berenice A Fischer1, Sonia T Chelbi1, Greta Guarda2.   

Abstract

Alterations in the Regulatory factor X 7 (RFX7) gene have recurrently been reported in lymphoid cancers. Uncharacterized until recently, this transcription factor regulates genes important for ciliogenesis and for limiting cellular metabolic activity. Here we discuss these observations and conjecture on the links between the reported functions of RFX7 and its potential role in lymphoid cancers, encouraging future studies in these directions.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  RFX7; ciliogenesis; leukemia; lymphoma; metabolism

Mesh:

Substances:

Year:  2019        PMID: 31952782     DOI: 10.1016/j.trecan.2019.11.001

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  3 in total

Review 1.  RFX1: a promising therapeutic arsenal against cancer.

Authors:  Joby Issac; Pooja S Raveendran; Ani V Das
Journal:  Cancer Cell Int       Date:  2021-05-08       Impact factor: 5.722

2.  TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation.

Authors:  Martin Fischer; Robert Schwarz; Konstantin Riege; James A DeCaprio; Steve Hoffmann
Journal:  NAR Cancer       Date:  2022-03-23

3.  p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance.

Authors:  Luis Coronel; David Häckes; Katjana Schwab; Konstantin Riege; Steve Hoffmann; Martin Fischer
Journal:  Oncogene       Date:  2021-12-14       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.